• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生理间接反应模型可描述多种类型的药效学效应。

Physiologic indirect response models characterize diverse types of pharmacodynamic effects.

作者信息

Jusko W J, Ko H C

机构信息

Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo 14260.

出版信息

Clin Pharmacol Ther. 1994 Oct;56(4):406-19. doi: 10.1038/clpt.1994.155.

DOI:10.1038/clpt.1994.155
PMID:7955802
Abstract

A family of four basic physiologic indirect response models has been proposed to account for the pharmacodynamics of drugs that act by way of inhibition or stimulation of the production or loss of endogenous substances or mediators. Such models were applied previously to account for the anticoagulant effects of warfarin, adrenal suppression by corticosteroids, cell trafficking effects of corticosteroids, antipyretic effects of ibuprofen, and aldose reductase inhibition. Additional responses that can be readily characterized with such models include muscular contraction from pyridostigmine, diuresis from furosemide, bronchodilation from terbutaline, prolactin secretion after cimetidine, and potassium suppression by terbutaline. This report shows that indirect response models, rather than "link" or "hypothetical effect compartment" models, may be more appropriate for diverse drugs when time lags exist between plasma or biophase drug concentrations and the time course of pharmacodynamic responses.

摘要

已经提出了一个由四个基本生理间接反应模型组成的家族,用于解释通过抑制或刺激内源性物质或介质的产生或损失起作用的药物的药效学。此类模型先前已用于解释华法林的抗凝作用、皮质类固醇对肾上腺的抑制作用、皮质类固醇的细胞转运作用、布洛芬的解热作用以及醛糖还原酶抑制作用。可以用此类模型轻松表征的其他反应包括新斯的明引起的肌肉收缩、呋塞米引起的利尿、特布他林引起的支气管扩张、西咪替丁后催乳素分泌以及特布他林引起的钾抑制。本报告表明,当血浆或生物相药物浓度与药效学反应的时间进程之间存在时间滞后时,间接反应模型而非“链接”或“假设效应室”模型可能更适用于多种药物。

相似文献

1
Physiologic indirect response models characterize diverse types of pharmacodynamic effects.生理间接反应模型可描述多种类型的药效学效应。
Clin Pharmacol Ther. 1994 Oct;56(4):406-19. doi: 10.1038/clpt.1994.155.
2
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.从基础到系统药效动力学模型的转变:皮质类固醇的经验教训。
Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101.
3
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.间接药效学模型的特点及其在临床药物反应中的应用。
Br J Clin Pharmacol. 1998 Mar;45(3):229-39. doi: 10.1046/j.1365-2125.1998.00676.x.
4
Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses.四种间接药效学反应基本模型性质的数学形式主义。
J Pharmacokinet Biopharm. 1997 Feb;25(1):107-23. doi: 10.1023/a:1025723927981.
5
Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.药代动力学/药效学(PK/PD)建模的基本概念。
Int J Clin Pharmacol Ther. 1997 Oct;35(10):401-13.
6
Role of dosage regimen in controlling indirect pharmacodynamic responses.给药方案在控制间接药效学反应中的作用。
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):45-57. doi: 10.1016/s0169-409x(00)00132-0.
7
Clinical pharmacokinetics of cholinesterase inhibitors.胆碱酯酶抑制剂的临床药代动力学。
Clin Pharmacokinet. 1986 May-Jun;11(3):236-49. doi: 10.2165/00003088-198611030-00005.
8
Approaches to pharmacokinetic/ pharmacodynamic modeling during pregnancy.孕期药代动力学/药效学建模方法。
Semin Perinatol. 2001 Jun;25(3):124-32. doi: 10.1053/sper.2001.24905.
9
Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.多次静脉给药后呋塞米耐受性的药效学建模
Clin Pharmacol Ther. 1996 Jul;60(1):75-88. doi: 10.1016/S0009-9236(96)90170-8.
10
Indirect pharmacodynamic response models do not require any parametric pharmacokinetic model to be fitted to effect-time data.间接药效学反应模型不需要将任何参数药代动力学模型拟合到效应-时间数据。
Methods Find Exp Clin Pharmacol. 1997 Dec;19(10):723-9.

引用本文的文献

1
Are plasma drug concentrations still necessary? Rethinking the pharmacokinetic link in dose-response relationships.血浆药物浓度仍然必要吗?重新思考剂量-反应关系中的药代动力学联系。
Front Pharmacol. 2025 Jul 29;16:1660323. doi: 10.3389/fphar.2025.1660323. eCollection 2025.
2
Tutorial for Modeling Delays in Biological Systems in the NONMEM Software.NONMEM软件中生物系统延迟建模教程。
CPT Pharmacometrics Syst Pharmacol. 2025 Jul;14(7):1133-1155. doi: 10.1002/psp4.70046. Epub 2025 Jun 16.
3
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Erythroferrone in Anemic Rats with Chronic Kidney Disease and Chemotherapy-Induced Anemia: An Early Biomarker for Hemoglobin Response and rHuEPO Hyporesponsiveness.
基于机制的红细胞生成素在慢性肾病和化疗诱导贫血的贫血大鼠中的药代动力学/药效学建模:血红蛋白反应和重组人促红细胞生成素低反应性的早期生物标志物
ACS Pharmacol Transl Sci. 2024 Dec 11;8(1):189-202. doi: 10.1021/acsptsci.4c00575. eCollection 2025 Jan 10.
4
A tutorial for model-based evaluation and translation of cardiovascular safety in preclinical trials.基于模型的临床前试验心血管安全性评价和转化的教程。
CPT Pharmacometrics Syst Pharmacol. 2024 Jan;13(1):5-22. doi: 10.1002/psp4.13082. Epub 2023 Nov 23.
5
The Physiological and Pharmacological Significance of the Circadian Timing of the HPA Axis: A Mathematical Modeling Approach.HPA 轴昼夜节律时间的生理和药理学意义:一种数学建模方法。
J Pharm Sci. 2024 Jan;113(1):33-46. doi: 10.1016/j.xphs.2023.08.005. Epub 2023 Aug 18.
6
Teaching computational systems biology with an eye on quantitative systems pharmacology at the undergraduate level: Why do it, who would take it, and what should we teach?在本科阶段着眼于定量系统药理学教授计算系统生物学:为何要这样做,谁会选修这门课程,以及我们应该教些什么?
Front Syst Biol. 2022;2. doi: 10.3389/fsysb.2022.1044281. Epub 2022 Nov 25.
7
Pretreatment of rhesus monkeys with transdermal patches containing physostigmine and procyclidine: implications of the delivery system for the potential application against VX nerve agent intoxication in humans.用含有毒扁豆碱和丙环定的透皮贴剂对恒河猴进行预处理:给药系统对其在人类中预防VX神经毒剂中毒潜在应用的影响。
Arch Toxicol. 2023 Mar;97(3):697-710. doi: 10.1007/s00204-022-03438-4. Epub 2023 Jan 12.
8
Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling.通过基于生理的药代动力学-药效学模型研究健康成年人群(包括CYP2C9基因多态性和各类患者群体)中的托拉塞米药代动力学。
Pharmaceutics. 2022 Dec 5;14(12):2720. doi: 10.3390/pharmaceutics14122720.
9
Fractional transit compartment model for describing drug delayed response to tumors using Mittag-Leffler distribution on age-structured PKPD model.基于分布时滞的年龄结构药代动力学药效动力学模型描述药物对肿瘤的迟发反应
PLoS One. 2022 Nov 4;17(11):e0276654. doi: 10.1371/journal.pone.0276654. eCollection 2022.
10
Starting dose selection of palbociclib in Chinese patients with breast cancer based on population kinetic-pharmacodynamic model of neutropenia.基于中性粒细胞减少的群体药动-药效动力学模型选择中国乳腺癌患者中帕博西尼的起始剂量。
Cancer Chemother Pharmacol. 2022 Dec;90(6):489-497. doi: 10.1007/s00280-022-04484-6. Epub 2022 Oct 22.